What is the current Price Target for the Aileron Therapeutics, Inc. stock?

The average Aileron Therapeutics, Inc. target price is $10.20. This is 684.62% higher than the current stock price. The highest price target is 707.69%, the lowest is 676.92%. 3 Analysts have issued a price target Aileron Therapeutics, Inc. 2026 .

How high will the Aileron Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Aileron Therapeutics, Inc. stock will rise. The performance of stocks, including the Aileron Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Aileron Therapeutics, Inc. stock today?

The performance of Aileron Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Aileron Therapeutics, Inc. stock fall?

The decline in Aileron Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Aileron Therapeutics, Inc. Forecast, price target & analysts

$1.30

2.99%

Nasdaq, Wed, Oct 15 2025

ISIN

US00887A1051

Symbol

ALRN

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts Strategies

Aileron Therapeutics, Inc. Target price 2025 - Analyst rating & recommendation

Aileron Therapeutics, Inc. Classifications & Recommendation:

Buy

75%

Hold

25%

Aileron Therapeutics, Inc. Price Target

Target Price	$10.20
Price	$1.30
Potential	684.62% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Aileron Therapeutics, Inc. 2026 . The average Aileron Therapeutics, Inc. target price is $10.20. This is 684.62% register free of charge higher than the current stock price. The highest price target is $10.50 707.69% register free of charge , the lowest is $10.10 676.92% register free of charge .
	A rating was issued by 8 analysts: 6 Analysts recommend Aileron Therapeutics, Inc. to buy, 2 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Aileron Therapeutics, Inc. stock has an average upside potential 2026 of 684.62% register free of charge . Most analysts recommend the Aileron Therapeutics, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-3.51	-0.94
	2.63%	73.22%
P/E		negative

3 Analysts have issued a Aileron Therapeutics, Inc. forecast for earnings per share. The average Aileron Therapeutics, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-3.51	2.63%
2025	$-0.94 73.22% Unlock
2026	$-0.55 41.49% Unlock
2027	$-0.55 0.00% Unlock

Current	-0.53	80.28%
2025	-1.39 160.89% Unlock
2026	-2.36 69.78% Unlock
2027	-2.36 0.00% Unlock

Aileron Therapeutics, Inc....

Current Aileron Therapeutics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 22 2025
Brookline Capital	Locked ➜ Locked	Locked	Aug 19 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 22 2025
Locked Brookline Capital: Locked ➜ Locked	Aug 19 2025

Discover more stocks with a high price target

TUI 47.87%

BioNTech SE - ADR 33.93%

Deutsche Telekom 31.88%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now